TCW Group »

Denali Therapeutics shares owned by TCW Group

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by TCW Group from 13F filings

Historical chart of TCW Group investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by TCW Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by TCW Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.9M 142k 20.63
2023-06-30 $2.7M 90k 29.51
2023-03-31 $2.0M 88k 23.04
2022-12-31 $1.1M 39k 27.81